Interleukin-18: A novel cytokine that augments both innate and acquired immunity

Advances in Immunology

Volumn 70, Issue , 1998, Pages 281-312

  Okamura, Haruki ^a   Tsutsui, Hiroko ^b   Kashiwamura, Shin Ichiro ^a   Yoshimoto, Tomohiro ^a,b   Nakanishi, Kenji ^a,b  

^a Institute for Advanced Medical Sciences   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 1BETA CONVERTING ENZYME;

ANTIBODY RESPONSE; B LYMPHOCYTE ACTIVATION; CYTOKINE PRODUCTION; HOST RESISTANCE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; LEISHMANIASIS; LIVER INJURY; MALARIA; MOLECULAR CLONING; MULTIPLE ORGAN FAILURE; NATURAL KILLER CELL; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ANIMALS; B-LYMPHOCYTES; HUMANS; IMMUNITY; INTERLEUKIN-18; KILLER CELLS, NATURAL; LYMPHOCYTE COOPERATION; MICE; TH1 CELLS; TH2 CELLS;

EID: 0033491194     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (111)

1. Adachi, M., Suematsu, S., Suda, T., Watanabe, D., Fukuyama, H., Ogasawara, J., Tanaka, T., Yoshida, N., and Nagata, S. (1996). Enhanced and accelerated lymphoproliferations in Fas-null mice. Proc. Natl. Acad. Sci. USA 93, 2131-2136.
2. Ahn, H.-J., Maruo, S., Tomura, M., Mu, J., Hamaoka, T., Nakanishi, K., Clark, S., Kurimoto, M., Okamura, H., and Fujiwara, H. (1997). A mechanism underlying synergy between IL-12 and IFN-γ-inducing factor in enhanced production of IFN-γ. J. Immunol.
3. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thomberry, N. A., Wong, W. W., and Yuan, J. (1996). Human ICE/CED-3 protease nomenclature. Cell 87, 171.
4. Baeuerle, P. A., and Henkel, T. (1994). Function and activation of NF-ΚB in the immune system. Annu. Rev. Immunol. 12, 141-179.
5. Bazan, J. F., Timans, J. C., and Kastelein, R. A. (1996). A newly defined interleukin-1? Nature 379, 591.
6. Belosevic, M., Finbloom, D. S., and van der Meide, P. H. (1989). Administration of monoclonal anti-IFN γ antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Exp. Med. 177, 1505-1509.
7. Billiau, A. (1996). Interferon-γ: Biology and role in pathogenesis. Adv. Immunol. 62,61-130.
8. Boehm, U., Klamp, T., Groot, M., and Howard, J. C. (1997). Cellular responses to interferon-γ. Annu. Rev. Immunol. 15, 749-795.
9. Cao, Z., Xiong, J., Takeuchi, M., Kurama, T., and Goeddel, D. V. (1996). TRAF6 is a signal transducer for Interleukin-1. Nature 383, 443-446.
10. Coffman, R. L., Ohara, J., Bond, M. W., Carty, J., Zlotnik, A., and Paul, W. E. (1986). B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J. Immunol. 136, 4538-4541.
11. Conti, B., Jahng, J., Tinti, C., Son, J., and Joh, T. (1997). Induction of interferion-γ inducing factor in the adrenal cortex. J. Biol. Chem. 264, 2035-2037.
12. Dao, T., Ohashi, K., and Kayano, T. (1996). Inteferon-y-inducing factor, a novel cytokine, enhances fas Iigand mediated cytotoxity of murine T helper 1 cells. Cell. Immunol. 173, 230-235.
13. Dinarello, C. (1989). Interleukin-1 and its biologically related cytokines. Adv. Immunol. 44, 153-205.
14. Dinarello, C. A., Gelfand, J. A., and Wolff, S. M. (1993). Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 269, 1829-1835.
15. + T cell-, interferon γ-, and nitric oxide-dependent immunity. J. Exp. Med. 183, 1739-1746.
16. int liver lymphocytes: Influence of thymus, β2-mifroglobulin and NK1.1 expression. Int. Immunol. 7, 1729-1739.
17. Farrar, M., and Schreiber, R. (1993). The molecular cell biology of interferon-g and its receptor. Annu. Rev. Immunol. 11, 571-611.
18. Finkehnan, F. D., Katona, I. M., Urban, J. J., Snapper, C. M., Ohara, J., and Paul, W. E. (1986). Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1. Proc. Natl. Acad. Sci. USA 83, 9675-9678.
19. Finkelman, F. D., Holmes, J., Katona, I. M., Urban, J. J., Beckmann, M. P., Park, L. S., Schooley, K. A., Coffman, R. L., Mosmann, T. R., and Paul, W. E. (1990). Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8, 303-333.
20. Finkelman, F. D., Madden, K. B., Cheever, A. W., Katona, I. M., Morris, S. C., Gately, M. K., Hubbard, B. R., Gause, W. C., and Urban, J. F. J. (1994). Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J. Exp. Med. 179, 1563-1572.
21. Gerard, C., Bruyns, C., Marchant, A., Abramowicz, D., Vanderabeele, P., Delvaux, A., Fiers, W., Goldmann, M., and Velu, T. (1993). Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177, 547-550.
22. Ghaynr, T., Banerjee, S., Hugunin, M., Butler, D., Herzog, L., Carter, A., Quinta, L., Sekut, L., Talanian, R., Paskind, M., Wong, W., Kamen, R., Tracey, D., and Allen, H. (1997). Caspase-1 processed IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 386, 619-623.
23. Ghosh, S., Latimer, R. D., Gray, B. M., Harwood, R. J., and Oduro, A. (1993). Endotoxin-induced organ injury. Crit. Care Med. 21, S19-S23.
24. Gu, Y., Kuida, K., Tsutsui, H., Ku, G., Hsiao, K., Fleming, M., Hayashi, N., Higashino, K., Okamura, H., Nakanishi, K., Kurimoto, M.,, Tanimoto, T.,, Flavell, R., Sato, V., Harding, M., Livingston, D., and Su, M. (1997). Activation of interf'eron-gamma inducing factor mediated by interleukin-lbeta converting enzyme. Science 275, 206-209.
25. Hall, S. S. (1995). IL-12 at the crossroads. Science 268, 1432-1434.
26. + lymphocytes in vivo during healing and progression of murine leishmaniasis. Proc. Natl. Acad. Sci. USA 88, 7011-7015.
27. Heinzel, F. P., Schoenhaut, D. S., Rerko, R. M., Rosser, L. E., and Gately, M. K. (1993). Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177, 1505-1509.
28. Heinzel, F. P., Rerko, R. M., and Pearlman, E. (1995). Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155, 730-739.
29. Henkart, P. A. (1996). ICE family proteases: Mediators of all apoptotic cell death? Immunity 4, 195-201.
30. Hoffman, S., Isenbarger, D., Long, G., Sedegah, M., Szarfman, A., Waters, L., Hollingdale, M., van der Meide, P., Finbloom, D., and Ballou, W. (1989). Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science 244, 1078-1081.
31. Hollingdale, M. R. (1983). Malaria and the liver. Hepatology 5, 327-335.
32. Howard, M., Nakanishi, K., and Paul, W. E. (1984). B cell growth and differentiation factors. Immunol. Rev. 78, 185-210.
33. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547-549.
34. Hsu, H., Shu, H. B., Pan, M. G., and Goeddel, D. V. (1995). TRADD-TRAF 2 and TRADDFADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308.
35. Kataoka, T., Shinohara, N., Takayama, H., Takaku, K., Kondo, S., Yonehara, S., and Nagai, K. (1996). Conanamycin A., a powerful tool for characterization and estimation of contribution of perforin-and Fas-based lytic pathways in cell-mediated cytotoxicity. J. Immunol. 156, 3678-3686.
36. Kishimoto, T. (1985). Factors affecting B cell growth and differentiation. Annu. Rev. Immunol. 3, 133-157.
37. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., and Trinchieri, G. (1989). Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-845.
38. Kohno, K., Kataoka, J., Ohtsuki, T., Suemoto, Y., Okamoto, I., Usui, M., Ikeda, M., and Kurimoto, M. (1997). IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J. Immunol. 158, 1541-1550.
39. Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S.-S., and Flavell, R. A. (1995). Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267, 2000-2003.
40. Kuida, K., Zheng, T. S., Na, S., Kuan, C., Yang, D., Karasuyama, H., Rakic, P., and Flavell, R. A. (1996). Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384, 368-373.
41. Kagi, D., Ledermann, B., Bürki, K., Zinkernagel, R. M., and Hengartner, H. (1996). Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14, 207-232.
42. Li, L., Young, D., Wolf, S. F., and Choi, Y. S. (1996). Interleukin-12 stimulates B cell growth by inducing IFN-γ. Cell. Immunol. 168, 133-140.
43. Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J., Towne, E., Tracyey, D., Wardwell, S., F.-Y., W., Wong, W., Kamen, R., and Seshadri, T. (1995). Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxin shock. Cell 80, 401-411.
44. Lindstein, T., June, C., Ledbetter, J., Stella, G., and Thompson, C. (1989). Regulation of lymphokine messenger RNA stability by a surface mediated T cell activation pathway. Science 244, 399-343.
45. + T cells but induces type 1 T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J. Immunol. 159, 97-106.
46. Matsumoto, S., Tsuji-Takayama, K., Aizawa, Y., Koide, K., Takeuchi, M., Ohta, T., and Kurimoto, M. (1997). Interleuldn-18 activates NF-ΚB in murine T helper type 1 cells. Biochem. Biophys. Res. Commun. 234, 454-457.
47. Meis, J. E. G. M., Verhave, J. P., Jap, P. H. K., and Meuwissen, J. H. E. (1983). An ultrastructual study on the role of Kuppfer cells in the process of infection by Plasmodium berghei in rats. Parasitology 86, 231-242.
48. Mellouk S., Green, S. J., Nacy, C. A., and Hoffman, S. L. (1991). IFN-γ inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J. Immunol. 146,3971-3976.
49. Micallef, M., Ohtsuki, T., Kohno, K., Tanabe, F., Ushio, S., Namba, M., Tanimoto, T., Torigoe, M., Fujii, M., Ikeda, M., and Kurimoto, M. (1996). IFN-γ-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: Synergism with interleukin-12 for interferon-γ production. Eur. J. Immunol. 26, 1647-1651.
50. Mosmann, T. R., and Coffman, R. L. (1989). TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173.
51. Muroi, M., N. Shiragami, Nagao, K., Yaamasaki, M., and Takatsuki, A. (1993). Folimycin (coneanamycin A), a specific inhibitor of V-ATPase, blocks intracellular translocation of the glycoprotein of vesicular stomatitis virus before arrival to the Golgi apparatus. Cell Struct. Funct. 18, 139-149.
52. Nagata, S. (1994). Fas and Fas ligand: A death factor and its receptor. Adv. Immunol. 57, 129-144.
53. Nagata, S., and Golstein, P. (1995). The Fas death factor. Science 267, 1449-1456.
54. Nakamura, K., Okamura, H., Nagata, K., Komatsu, T., and Tamura, T. (1993). Purification of a factor which provides a costimulatory signal for gamma interferon production. Infect. Immun. 61, 64-70.
55. Nakamura, K., Okamura, H., Wada, K., Nagata, K., Komatsu, T., and Tamura, T. (1989). Endotoxin-induced serum factor that stimulates gamma interferon production. Infect. Immun. 38, 590-595.
56. Nakanishi, K., Cohen, D. I., Blackman, M., Nielsen, E., Ohara, J., Hamaoka, T., Koshland, M. E., and Paul, W. E. (1984a). Ig RNA expression in normal B cells stimulated with anti-IgM antibody and T cell-derived growth and differentiation factors. J. Exp. Med. 160, 1736-1751.
57. Nakanishi, K., Malek, T., Smith, K., Hamaoka, T., Shevach, E., and Paul, W. (1984b). Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factor in IgM synthesis. J. Exp. Med. 160, 1605-1621.
58. Nakanishi, K., Yoshimoto, T., Chu, C. C., Matsumoto, H., Hase, K., Nagai, N., Tanaka, T., Miyasaka, M., Paul, W. E., and Shinka, S. (1995). IL-2 inhibits IL-4-dependent IgE and IgG1 production in vitro and in vivo. Int. Immunol. 7, 259-268.
59. Nussenzweig, V., and Nussenzweig, R. (1989). Rationale for the development of an engineered oporozoite malaria vaccine. Adv. Immunol. 45, 283-334.
60. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasuga, T., Kitamura, Y., and Nagata, S. (1993). Lethal effect of the anti-Fas antibody in mice. Nature 364,806-809.
61. Okamura, H., Kawaguchi, K., Shoji, K., and Kawade, Y. (1982). High-level induction of gamma interferon with various mitogens in mice pretreated with Propionibacterium acnes. Infect. Immun. 38, 440-443.
62. Okamura, H., Tsutsi, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nakuda, Y., Hattori, K., Akita, K., Narnba, M., Tanabe, F., Konishi, K., Fykuda, S., and Kurimoto, M. (1995a). Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378, 88-91.
63. Okamura, H., Nagata, K., Komatsu, T., Tanimoto, T., Nukata, Y., Tanabe, F., Akita, K., Torigoe, K., Okura, T., Fukuda, S., and Kurimoto, M. (1995b). A novel costimulatory factor for gamma interferon induction found in the liver of mice causes endotoxic shock. Infect. Immun. 63, 3966-3972.
64. Pamet, P., Garka, K. E., Bonnet, T. P., Dower, S. K., and Sim, J. E. (1996). IL-1Rrp is a novel receptor-like molecule similar to the type I interleukm-1 receptor and its homologues T1/ST2 and IL-1RAcP. J. Biol. Chem. 271, 3967-3970.
65. Pistoia, V., Cozzolino, F., Rubartelli, A., Torcia, M., Roncella, S., and Ferrarini, M. (1986). In vitro production of interleukin 1 by normal and malignant human B lymphocytes. J. Immunol. 136, 1688-1692.
66. + T cells both contribute to acquired immunity to blood-stage Plasmodium chahaudi AS. Infect. Immun. 59, 51-58.
67. Reiner, S. L., and Locksley, R. M. (1995). The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13, 151-177.
68. Rothe, H., Jenkins, N., Copeland, N., and Kolb, H. (1997). Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF., which is located near Idd2. J. Clin. Invest. 99, 469-474.
69. Rothe, M., Burkart, V., Faust, A., and Kolb, H. (1996). Interleukin-12 gene expression is associated with development of diabetes mellitus in non-obese diabetes mice. Diabetologia 39, 119-122.
70. Sadick, M. D., Heinzel, F. P., Holaday, B. J., Pu, R. T., Dawkins, R. S., and Locksley, R. M. (1990). Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody: Evidence for a T cell-dependent, interferon gamma-independent mechanism. J. Exp. Med. 171, 115-127.
71. + T cells and antibodies are required for immunity to malaria sporozoites. Nature 330, 664-666.
72. Sedegah, M. S., Finkelman, F., and Hoffman, S. L. (1994). Interleukin 12 induction of interferon γ-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91,10700-10702.
73. + T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90, 10188-10192.
74. + T cells. Annu. Rev. Immunol. 12, 635-673.
75. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176, 1091-1098.
76. Shehedeh, N. N., LaRosa, F., and Lafferty, K. J. (1993). Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmune. 6, 291-300.
77. Sher, A., and Coffman, R. (1992). Regulation of immunity to parasites by T cells and T-cell-derived cytokines. Annu. Rev. Immunol. 10, 385-409.
78. Singer, I. I., Scott, S., Chin, J., Bayne, E. K., Limjuco, G., Widner, J., Miller, D. K., Chapmann, K., and Kostura, M. J. (1995). The interleukin-1β-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J. Exp. Med. 182, 1447-1459.
79. Smeland, E. B., Blomhoff, H. K., Fundenid, S., Shalaby, M. R., and Espevik, T. (1989). Interleukin 4 induces selective production of interleukin 6 from normal human B lymphocytes. J. Exp. Med. 170, 1463-1468.
80. Smith, C. A., Williams, G. T., Kinston, R., Jenkinson, E. J., and Owen J. J. (1989). Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337, 181-184.
81. Snapper, C. M., and Paul, W. E. (1987). Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236, 944-947.
82. Stevenson, M. M., Tarn, M. F., Wolf, S. F., and Sher, A. (1995). IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155, 2545-2556.
83. Stoll, S., Muller, G., Kurimoto, M., Saloga, J., Tanimoto, T., Yamauchi, H., Okamura, H., Knop, J., and Enk A. H. (1997). Production of IL-18 (IFN-γ-inducing factor) messenger RNA and functional protein by murine keratinocytes. J. Immunol. 159, 298-302.
84. Swain, S. L., Bradley, L. M., Croft, M., Tonkowagy, S., Atkins, G., Weinberg, A. D., Duncan, D. D., Hedrick, S. M., Dutton, R. W., and Huston, G. (1991). Helper T-cell subsets: Phenotype, function and the role of lymphokines in regulating their development. Immunol. Rev. 123, 115-144.
85. Swain S. L., Weinberg, A. D., English, M., and Huston, G. (1990). IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145, 3796-3806.
86. Szabo, S. J., Dighe, A. S., Gubler, U., and Murphy, K. M. (1997). Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper (Th1) and Th2 cells. J. Exp. Med. 185, 817-824.
87. Szabo, S. J., Jacobson, N. G., Dighe, A. S., Gubler, U., and Murphy, K. M. (1995). Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2, 665-675.
88. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., and Nagata S. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
89. Tanaka, M., Suda, T., Yatomi, T., Nakamura, N., and Nagata S. (1997). Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes. J. Immunol. 158, 2302-2309.
90. Tanaka, Y., Takahashi, A., Watanabe, K., Takayama, K., Yahata, T., Habu, S., and Nishimura T. (1996). A pivotal role off IL-12 in Th-1 dependent mouse liver injury. Int. Immunol. 8, 569-576.
91. + T cell lines raised against Plasmodium chabaudi show characteristics of either Th1 or Th2 cells. Parasite Immunol. 15, 301-310.
92. Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., Elliston, K. O., Ayala, J. M., Casano, F. J., Chin, J., Ding, G. F.-F., Egger, L. A., Gaffney, E. P., Limjuco, G., Palyha, O. D., Raju, S. M., Rolando, A. M., Salley, J. P., Yamin, T. T., Lee, T. D., Shively, J. E., MacCross, M., Mumford, R. A., Schmidt, J. A., and Tocci, M. J. (1992). A novel heterodimeric cysteine protease is required for interIeukin-1β processing in monocytes. Nature 356, 768-774.
93. Torigoe, K., Ushio, S., Okura, T., Kobayashi, S., Taniai, M., Kinikata, T., Murakami, T., Sanou, O., Kojima, H., Fuji, M., Ohta, T., Ikeda, M., Ikegami, H., and Kurimoto, M. (1997). Functional and characterization of the human Interleukin-18 (hIL-18) receptor. J. Biol. Chem. 272, 25737-25742.
94. Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately M., and Adorini, L. (1995). Interleukin-12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181, 817-821.
95. Trinchieri, G. (1995). Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific and adaptive immunity. Annu. Rev. Immunol. 13, 251-276.
96. Tsutsui, H., Matsui, K., Kawada, N., Hyodo, Y., Hayashi, N., Okamura, H., Higashino, K., and Nakanishi, K. (1997). IL-18 accounts for both TNF-α- and FasL-mediated hepatotoxic pathways in endotoxin-induced liver injury. J. Immunol. 159, 3961-3967.
97. Tsutsui, H., Mizoguchi, Y., and Morisawa S. (1992). Importance of direct hepatocytolysis by liver macrophages in experimental fulminant hepatitis. Hepato-Gastroenterol. 39, 553-559.
98. Tsutsui, H., Nakanishi, K., Matsui, K., Higashino, K., Okamura, H., Miyazawa, Y., and Kaneda K. (1996). Interferon-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 157, 3967-3973.
99. Udagawa, N., Horwood, N. J., Elliott, J., Mackay, A., Owens, J., Okamura, H., Kurimoto, M., Chambers, T. J., Martin, T. J., and Gillespie, M. T. (1997). Interleukin-18 (interferon-γ-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-g to inhibit osteoclast formation. J. Exp. Med. 185, 1005-1012.
100. Ushio, S., Namba, M., Okura, T., Hattori, K., Nukada, Y., Aldta, K., Tanabe, F., Konishi, K., Micallef, M., Fujii, M., Torigoe, K., Tanimoto, T., Fukuda, S., Ikeda, M., Okamura, H., and Kurimoto, M. (1996). Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol. 156, 4274-4279.
101. + T-cell subsets. Proc. Natl. Acad. Sci. USA 91, 18-22.
102. Vogel, S. N., Moore, R. N., Sipe, J. D., and Rosenstereich, D. L. (1980). BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies. J. Immunol. 124, 2004-2009.
103. Wada, M., Okamura, H., Nagata, K., Shimoyama, T., and Kawada, Y. (1985). Cellular mechanisms in in vivo production of gamma interferon induced by Iipopolysaccharide in mice infected with Mycobacterium bovis BCG. J. Interferon Res. 5, 431-443.
104. ; Herzog, L., Hugunin, M., Houy, W. Mankovich, J. A., McGuiness, L., Orienwicz, E., Paskind, M., Pratt, C. A., Reis, P., Summani, A., Terranova, M., Wich, J. P., Xiong, L., Miller, A., Tracey, D. E., Kamen, R., and Wong W. W. (1994). Crystal structure of the cysteine protese interleukin-1βconverting enzyme: A (p20/pl0)2 homodimer. Cell 78, 343-352.
105. Wheelock, E. (1965). Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science 149, 310-311.
106. Wu, J., Zhou, T., Zahng, J., He, J., Gause, W. C., and Mountz, J. D. (1994). Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of trangenic MRL-lpr/lpr mice. Proc. Natl. Acad. Sci. USA 91, 2344-2348.
107. Yoshimoto, T., Nakanishi, K., Hirose, K., Hiroishi, K., Okamura, H., Takemoto, Y., Kanamaru, A., Hada, T., Tamura, T., Kakishita, E., and Higashino, K. (1992). High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor. J. Immunol. 148, 3596-3603.
108. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179, 1285-1295.
109. + T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. USA 92, 11931-11934.
110. H2 response and immunoglobulin E production. Science 270, 1845-1847.
111. Yoshimoto, T., Okamura, H., Tagawa, Y., Iwakura, Y., and Nakanishi, K. (1997). Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-γ production from activated B cells. Proc. Natl. Acad. Sci. USA 94, 3948-3953.